{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:58:04Z","timestamp":1775872684129,"version":"3.50.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["575534"],"award-info":[{"award-number":["575534"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["575534"],"award-info":[{"award-number":["575534"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092789"],"award-info":[{"award-number":["1092789"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1092789"],"award-info":[{"award-number":["1092789"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1173046"],"award-info":[{"award-number":["1173046"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1077626"],"award-info":[{"award-number":["1077626"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The pathogenesis of malaria in pregnancy (MiP) involves accumulation of\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      -infected red blood cells (pRBCs) in the placenta, contributing to poor pregnancy outcomes. Parasite accumulation is primarily mediated by\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      erythrocyte membrane protein 1 (PfEMP1). Magnitude of IgG to pRBCs has been associated with reduced risk of MiP in some studies, but associations have been inconsistent. Further, antibody effector mechanisms are poorly understood, and the role of antibody complement interactions is unknown.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Studying a longitudinal cohort of pregnant women (\n                      <jats:italic>n<\/jats:italic>\n                      =302) from a malaria-endemic province in Papua New Guinea (PNG), we measured the ability of antibodies to fix and activate complement using placental binding pRBCs and PfEMP1 recombinant domains. We determined antibody-mediated complement inhibition of pRBC binding to the placental receptor, chondroitin sulfate A (CSA), and associations with protection against placental parasitemia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Some women acquired antibodies that effectively promoted complement fixation on placental-binding pRBCs. Complement fixation correlated with IgG1 and IgG3 antibodies, which dominated the response. There was, however, limited evidence for membrane attack complex activity or pRBC lysis or killing. Importantly, a higher magnitude of complement fixing antibodies was prospectively associated with reduced odds of placental infection at delivery. Using genetically modified\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      and recombinant PfEMP1 domains, we found that complement-fixing antibodies primarily targeted a specific variant of PfEMP1 (known as VAR2CSA). Furthermore, complement enhanced the ability of antibodies to inhibit pRBC binding to CSA, which was primarily mediated by complement C1q protein.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings provide new insights into mechanisms mediating immunity to MiP and reveal potential new strategies for developing malaria vaccines that harness antibody-complement interactions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-021-02061-x","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T21:02:13Z","timestamp":1629752533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Reduced risk of placental parasitemia associated with complement fixation on Plasmodium falciparum by antibodies among pregnant women"],"prefix":"10.1186","volume":"19","author":[{"given":"D. Herbert","family":"Opi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle J.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair R. D.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Reiling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo-Anne","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle I.","family":"Stanisic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Ura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freya J. I.","family":"Fowkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Rogerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"key":"2061_CR1","unstructured":"WHO. World Malaria Report 2019 [Available from: https:\/\/www.who.int\/publications\/i\/item\/world-malaria-report-2019."},{"issue":"10","key":"2061_CR2","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1128\/IAI.70.10.5412-5415.2002","volume":"70","author":"JG Beeson","year":"2002","unstructured":"Beeson JG, Amin N, Kanjala M, Rogerson SJ. Selective accumulation of mature asexual stages of Plasmodium falciparum-infected erythrocytes in the placenta. Infect Immun. 2002;70(10):5412\u20135. https:\/\/doi.org\/10.1128\/IAI.70.10.5412-5415.2002.","journal-title":"Infect Immun."},{"issue":"3","key":"2061_CR3","first-page":"330","volume":"109","author":"PR Walter","year":"1982","unstructured":"Walter PR, Garin Y, Blot P. Placental pathologic changes in malaria. A histologic and ultrastructural study. Am J Pathol. 1982;109(3):330\u201342.","journal-title":"Am J Pathol."},{"issue":"1","key":"2061_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1084\/jem.182.1.15","volume":"182","author":"SJ Rogerson","year":"1995","unstructured":"Rogerson SJ, Chaiyaroj SC, Ng K, Reeder JC, Brown GV. Chondroitin sulfate A is a cell surface receptor for Plasmodium falciparum-infected erythrocytes. J Exp Med. 1995;182(1):15\u201320. https:\/\/doi.org\/10.1084\/jem.182.1.15.","journal-title":"J Exp Med."},{"issue":"5267","key":"2061_CR5","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1126\/science.272.5267.1502","volume":"272","author":"M Fried","year":"1996","unstructured":"Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science. 1996;272(5267):1502\u20134. https:\/\/doi.org\/10.1126\/science.272.5267.1502.","journal-title":"Science."},{"issue":"1","key":"2061_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/71582","volume":"6","author":"JG Beeson","year":"2000","unstructured":"Beeson JG, Rogerson SJ, Cooke BM, Reeder JC, Chai W, Lawson AM, et al. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat Med. 2000;6(1):86\u201390. https:\/\/doi.org\/10.1038\/71582.","journal-title":"Nat Med."},{"issue":"5537","key":"2061_CR7","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1126\/science.1062891","volume":"293","author":"K Flick","year":"2001","unstructured":"Flick K, Scholander C, Chen Q, Fernandez V, Pouvelle B, Gysin J, et al. Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science. 2001;293(5537):2098\u2013100. https:\/\/doi.org\/10.1126\/science.1062891.","journal-title":"Science."},{"issue":"9","key":"2061_CR8","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1084\/jem.20041579","volume":"200","author":"A Salanti","year":"2004","unstructured":"Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P, et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med. 2004;200(9):1197\u2013203. https:\/\/doi.org\/10.1084\/jem.20041579.","journal-title":"J Exp Med."},{"key":"2061_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/3-540-29967-x_6","volume":"297","author":"JG Beeson","year":"2005","unstructured":"Beeson JG, Duffy PE. The immunology and pathogenesis of malaria during pregnancy. Curr Top Microbiol Immunol. 2005;297:187\u2013227. https:\/\/doi.org\/10.1007\/3-540-29967-x_6.","journal-title":"Curr Top Microbiol Immunol."},{"issue":"1","key":"2061_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-019-1467-6","volume":"18","author":"JC Cutts","year":"2020","unstructured":"Cutts JC, Agius PA, Zaw L, Powell R, Moore K, Draper B, et al. Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review. BMC Med. 2020;18(1):14. https:\/\/doi.org\/10.1186\/s12916-019-1467-6.","journal-title":"BMC Med"},{"issue":"6705","key":"2061_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/27570","volume":"395","author":"M Fried","year":"1998","unstructured":"Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE. Maternal antibodies block malaria. Nature. 1998;395(6705):851\u20132. https:\/\/doi.org\/10.1038\/27570.","journal-title":"Nature."},{"issue":"5","key":"2061_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040181","volume":"4","author":"J Keen","year":"2007","unstructured":"Keen J, Serghides L, Ayi K, Patel SN, Ayisi J, van Eijk A, et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med. 2007;4(5):e181. https:\/\/doi.org\/10.1371\/journal.pmed.0040181.","journal-title":"PLoS Med."},{"issue":"5","key":"2061_CR13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S1473-3099(19)30739-X","volume":"20","author":"SB Sirima","year":"2020","unstructured":"Sirima SB, Richert L, Chene A, Konate AT, Campion C, Dechavanne S, et al. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study. Lancet Infect Dis. 2020;20(5):585\u201397. https:\/\/doi.org\/10.1016\/S1473-3099(19)30739-X.","journal-title":"Lancet Infect Dis."},{"issue":"9","key":"2061_CR14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cid\/ciy1140","volume":"69","author":"B Mordmuller","year":"2019","unstructured":"Mordmuller B, Sulyok M, Egger-Adam D, Resende M, de Jongh WA, Jensen MH, et al. First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria. Clin Infect Dis. 2019;69(9):1509\u201316. https:\/\/doi.org\/10.1093\/cid\/ciy1140.","journal-title":"Clin Infect Dis."},{"issue":"9","key":"2061_CR15","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1128\/IAI.73.9.5903-5907.2005","volume":"73","author":"SR Elliott","year":"2005","unstructured":"Elliott SR, Brennan AK, Beeson JG, Tadesse E, Molyneux ME, Brown GV, et al. Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity. Infect Immun. 2005;73(9):5903\u20137. https:\/\/doi.org\/10.1128\/IAI.73.9.5903-5907.2005.","journal-title":"Infect Immun."},{"issue":"7","key":"2061_CR16","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1128\/IAI.73.7.4112-4118.2005","volume":"73","author":"R Megnekou","year":"2005","unstructured":"Megnekou R, Staalsoe T, Taylor DW, Leke R, Hviid L. Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens. Infect Immun. 2005;73(7):4112\u20138. https:\/\/doi.org\/10.1128\/IAI.73.7.4112-4118.2005.","journal-title":"Infect Immun."},{"key":"2061_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.","journal-title":"Front Immunol"},{"issue":"1","key":"2061_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/imr.12802","volume":"293","author":"L Kurtovic","year":"2020","unstructured":"Kurtovic L, Boyle MJ, Opi DH, Kennedy AT, Tham WH, Reiling L, et al. Complement in malaria immunity and vaccines. Immunological reviews. 2020;293(1):38\u201356. https:\/\/doi.org\/10.1111\/imr.12802.","journal-title":"Immunological reviews."},{"key":"2061_CR19","first-page":"262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262.","journal-title":"Front Immunol"},{"issue":"4","key":"2061_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.chom.2009.09.003","volume":"6","author":"E Mehlhop","year":"2009","unstructured":"Mehlhop E, Nelson S, Jost CA, Gorlatov S, Johnson S, Fremont DH, et al. Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus. Cell Host Microbe. 2009;6(4):381\u201391. https:\/\/doi.org\/10.1016\/j.chom.2009.09.003.","journal-title":"Cell Host Microbe."},{"issue":"3","key":"2061_CR21","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","volume":"42","author":"MJ Boyle","year":"2015","unstructured":"Boyle MJ, Reiling L, Feng G, Langer C, Osier FH, Aspeling-Jones H, et al. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria. Immunity. 2015;42(3):580\u201390. https:\/\/doi.org\/10.1016\/j.immuni.2015.02.012.","journal-title":"Immunity."},{"issue":"1","key":"2061_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41467-019-08528-z","volume":"10","author":"L Reiling","year":"2019","unstructured":"Reiling L, Boyle MJ, White MT, Wilson DW, Feng G, Weaver R, et al. Targets of complement-fixing antibodies in protective immunity against malaria in children. Nat Commun. 2019;10(1):610. https:\/\/doi.org\/10.1038\/s41467-019-08528-z.","journal-title":"Nat Commun."},{"issue":"1","key":"2061_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12916-018-1054-2","volume":"16","author":"L Kurtovic","year":"2018","unstructured":"Kurtovic L, Behet MC, Feng G, Reiling L, Chelimo K, Dent AE, et al. Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children. BMC medicine. 2018;16(1):61. https:\/\/doi.org\/10.1186\/s12916-018-1054-2.","journal-title":"BMC medicine."},{"key":"2061_CR24","doi-asserted-by":"crossref","unstructured":"Behet MC, Kurtovic L, van Gemert GJ, Haukes CM, Siebelink-Stoter R, Graumans W, et al. The complement system contributes to functional antibody-mediated responses induced by immunization with Plasmodium falciparum malaria sporozoites. Infect Immun. 2018.","DOI":"10.1128\/IAI.00920-17"},{"issue":"8","key":"2061_CR25","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1128\/iai.65.8.3017-3023.1997","volume":"65","author":"J Healer","year":"1997","unstructured":"Healer J, McGuinness D, Hopcroft P, Haley S, Carter R, Riley E. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infect Immun. 1997;65(8):3017\u201323. https:\/\/doi.org\/10.1128\/iai.65.8.3017-3023.1997.","journal-title":"Infect Immun."},{"issue":"10","key":"2061_CR26","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/eji.1830271034","volume":"27","author":"J Wiesner","year":"1997","unstructured":"Wiesner J, Jomaa H, Wilhelm M, Tony HP, Kremsner PG, Horrocks P, et al. Host cell factor CD59 restricts complement lysis of Plasmodium falciparum-infected erythrocytes. Eur J Immunol. 1997;27(10):2708\u201313. https:\/\/doi.org\/10.1002\/eji.1830271034.","journal-title":"Eur J Immunol."},{"issue":"2","key":"2061_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0161-5890(84)90129-9","volume":"21","author":"HA Stanley","year":"1984","unstructured":"Stanley HA, Mayes JT, Cooper NR, Reese RT. Complement activation by the surface of Plasmodium falciparum infected erythrocytes. Mol Immunol. 1984;21(2):145\u201350. https:\/\/doi.org\/10.1016\/0161-5890(84)90129-9.","journal-title":"Mol Immunol."},{"issue":"2","key":"2061_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.chom.2013.01.010","volume":"13","author":"AL Conroy","year":"2013","unstructured":"Conroy AL, Silver KL, Zhong K, Rennie M, Ward P, Sarma JV, et al. Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria. Cell Host Microbe. 2013;13(2):215\u201326. https:\/\/doi.org\/10.1016\/j.chom.2013.01.010.","journal-title":"Cell Host Microbe."},{"issue":"5","key":"2061_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/trstmh\/trv019","volume":"109","author":"DI Stanisic","year":"2015","unstructured":"Stanisic DI, Moore KA, Baiwog F, Ura A, Clapham C, King CL, et al. Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New Guinea. Trans R Soc Trop Med Hyg. 2015;109(5):313\u201324. https:\/\/doi.org\/10.1093\/trstmh\/trv019.","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"3","key":"2061_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2559.1993.tb00110.x","volume":"22","author":"JN Bulmer","year":"1993","unstructured":"Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM. Placental malaria. I. Pathological classification. Histopathology. 1993;22(3):211\u20138. https:\/\/doi.org\/10.1111\/j.1365-2559.1993.tb00110.x.","journal-title":"I. Pathological classification. Histopathology."},{"issue":"3","key":"2061_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1365-2559.1993.tb00111.x","volume":"22","author":"JN Bulmer","year":"1993","unstructured":"Bulmer JN, Rasheed FN, Morrison L, Francis N, Greenwood BM. Placental malaria. II. A semi-quantitative investigation of the pathological features. Histopathology. 1993;22(3):219\u201325. https:\/\/doi.org\/10.1111\/j.1365-2559.1993.tb00111.x.","journal-title":"Histopathology"},{"issue":"1","key":"2061_CR32","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1073\/pnas.0305306101","volume":"101","author":"IA Cockburn","year":"2004","unstructured":"Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, Baisor M, et al. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A. 2004;101(1):272\u20137. https:\/\/doi.org\/10.1073\/pnas.0305306101.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"2061_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.mib.2006.06.009","volume":"9","author":"TN Williams","year":"2006","unstructured":"Williams TN. Human red blood cell polymorphisms and malaria. Curr Opin Microbiol. 2006;9(4):388\u201394. https:\/\/doi.org\/10.1016\/j.mib.2006.06.009.","journal-title":"Curr Opin Microbiol."},{"issue":"4","key":"2061_CR34","doi-asserted-by":"publisher","first-page":"828","DOI":"10.4269\/ajtmh.2010.09-0713","volume":"83","author":"E Lin","year":"2010","unstructured":"Lin E, Tavul L, Michon P, Richards JS, Dabod E, Beeson JG, et al. Minimal association of common red blood cell polymorphisms with Plasmodium falciparum infection and uncomplicated malaria in Papua New Guinean school children. Am J Trop Med Hyg. 2010;83(4):828\u201333. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0713.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"2061_CR35","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1365-2958.2005.04577.x","volume":"56","author":"MF Duffy","year":"2005","unstructured":"Duffy MF, Byrne TJ, Elliott SR, Wilson DW, Rogerson SJ, Beeson JG, et al. Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol Microbiol. 2005;56(3):774\u201388. https:\/\/doi.org\/10.1111\/j.1365-2958.2005.04577.x.","journal-title":"Mol Microbiol."},{"key":"2061_CR36","doi-asserted-by":"publisher","unstructured":"Maier AG, Rug M, O'Neill MT, Beeson JG, Marti M, Reeder J, et al. Skeleton-binding protein 1 functions at the parasitophorous vacuole membrane to traffic PfEMP1 to the Plasmodium falciparum-infected erythrocyte surface. Blood. 2007;109(3):1289\u201397. https:\/\/doi.org\/10.1182\/blood-2006-08-043364.","DOI":"10.1182\/blood-2006-08-043364"},{"key":"2061_CR37","doi-asserted-by":"publisher","unstructured":"Hommel M, Elliott SR, Soma V, Kelly G, Fowkes FJ, Chesson JM, et al. Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. Infect Immun. 2010;78(5):1963\u201378. https:\/\/doi.org\/10.1128\/IAI.01365-09.","DOI":"10.1128\/IAI.01365-09"},{"issue":"2","key":"2061_CR38","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1086\/314899","volume":"180","author":"JG Beeson","year":"1999","unstructured":"Beeson JG, Brown GV, Molyneux ME, Mhango C, Dzinjalamala F, Rogerson SJ. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties. J Infect Dis. 1999;180(2):464\u201372. https:\/\/doi.org\/10.1086\/314899.","journal-title":"J Infect Dis."},{"issue":"1","key":"2061_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1475-2875-8-143","volume":"8","author":"M Avril","year":"2009","unstructured":"Avril M, Hathaway MJ, Cartwright MM, Gose SO, Narum DL, Smith JD. Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastoris. Malar J. 2009;8(1):143. https:\/\/doi.org\/10.1186\/1475-2875-8-143.","journal-title":"Malar J."},{"issue":"4","key":"2061_CR40","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1128\/IAI.00071-12","volume":"80","author":"YL Tutterrow","year":"2012","unstructured":"Tutterrow YL, Avril M, Singh K, Long CA, Leke RJ, Sama G, et al. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun. 2012;80(4):1479\u201390. https:\/\/doi.org\/10.1128\/IAI.00071-12.","journal-title":"Infect Immun."},{"issue":"9","key":"2061_CR41","doi-asserted-by":"publisher","first-page":"e12558","DOI":"10.1371\/journal.pone.0012558","volume":"5","author":"P Fernandez","year":"2010","unstructured":"Fernandez P, Petres S, Mecheri S, Gysin J, Scherf A. Strain-transcendent immune response to recombinant Var2CSA DBL5-epsilon domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions. PLoS One. 2010;5(9):e12558.","journal-title":"PLoS One"},{"issue":"8","key":"2061_CR42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1086\/529526","volume":"197","author":"AV Oleinikov","year":"2008","unstructured":"Oleinikov AV, Francis SE, Dorfman JR, Rossnagle E, Balcaitis S, Getz T, et al. VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native protein. J Infect Dis. 2008;197(8):1119\u201323. https:\/\/doi.org\/10.1086\/529526.","journal-title":"J Infect Dis."},{"issue":"2","key":"2061_CR43","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1371\/journal.ppat.0040042","volume":"4","author":"P Andersen","year":"2008","unstructured":"Andersen P, Nielsen MA, Resende M, Rask TS, Dahlback M, Theander T, et al. Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA. PLoS Pathog. 2008;4(2):e42. https:\/\/doi.org\/10.1371\/journal.ppat.0040042.","journal-title":"PLoS Pathog."},{"issue":"5","key":"2061_CR44","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/500146","volume":"193","author":"NG Tuikue Ndam","year":"2006","unstructured":"Tuikue Ndam NG, Salanti A, Le-Hesran JY, Cottrell G, Fievet N, Turner L, et al. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. J Infect Dis. 2006;193(5):713\u201320. https:\/\/doi.org\/10.1086\/500146.","journal-title":"J Infect Dis."},{"issue":"1","key":"2061_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13071-018-2653-7","volume":"11","author":"M Hommel","year":"2018","unstructured":"Hommel M, Chan JA, Umbers AJ, Langer C, Rogerson SJ, Smith JD, et al. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays. Parasites Vectors. 2018;11(1):69. https:\/\/doi.org\/10.1186\/s13071-018-2653-7.","journal-title":"Parasites Vectors."},{"issue":"35","key":"2061_CR46","doi-asserted-by":"publisher","first-page":"23611","DOI":"10.1016\/S0021-9258(18)54327-1","volume":"266","author":"F Turrini","year":"1991","unstructured":"Turrini F, Arese P, Yuan J, Low PS. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J Biol Chem. 1991;266(35):23611\u20137. https:\/\/doi.org\/10.1016\/S0021-9258(18)54327-1.","journal-title":"J Biol Chem."},{"key":"2061_CR47","doi-asserted-by":"publisher","unstructured":"Chan JA, Howell KB, Reiling L, Ataide R, Mackintosh CL, Fowkes FJ, et al Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J Clin Invest. 2012;122(9):3227\u201338. https:\/\/doi.org\/10.1172\/JCI62182.","DOI":"10.1172\/JCI62182"},{"key":"2061_CR48","doi-asserted-by":"publisher","unstructured":"Bockhorst J, Lu F, Janes JH, Keebler J, Gamain B, Awadalla P, et al. Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA. Mol Biochem Parasitol. 2007;155(2):103\u201312. https:\/\/doi.org\/10.1016\/j.molbiopara.2007.06.007.","DOI":"10.1016\/j.molbiopara.2007.06.007"},{"key":"2061_CR49","doi-asserted-by":"publisher","unstructured":"Beeson JG, Mann EJ, Byrne TJ, Caragounis A, Elliott SR, Brown GV, et al. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. J Infect Dis. 2006;193(5):721\u201330. https:\/\/doi.org\/10.1086\/500145.","DOI":"10.1086\/500145"},{"key":"2061_CR50","doi-asserted-by":"crossref","unstructured":"Beeson JG, Ndungu F, Persson KE, Chesson JM, Kelly GL, Uyoga S, Hallamore SL, Williams TN, Reeder JC, Brown GV, Marsh K. Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa. Am J Trop Med Hyg. 2007;77(1):22-8.","DOI":"10.4269\/ajtmh.2007.77.22"},{"key":"2061_CR51","doi-asserted-by":"crossref","unstructured":"Larsen MD, Quintana MDP, Ditlev SB, Bayarri-Olmos R, Ofori MF, Hviid L, et al. Evasion of classical complement pathway activation on plasmodium falciparum-infected erythrocytes opsonized by PfEMP1-specific IgG. Front Immunol. 2018;9:3088.","DOI":"10.3389\/fimmu.2018.03088"},{"key":"2061_CR52","doi-asserted-by":"publisher","unstructured":"Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun. 2008;76(5):2240\u20138. https:\/\/doi.org\/10.1128\/IAI.01585-07","DOI":"10.1128\/IAI.01585-07"},{"key":"2061_CR53","doi-asserted-by":"publisher","unstructured":"Valmaseda A, Macete E, Nhabomba A, Guinovart C, Aide P, Bardaji A, et al. Identifying immune correlates of protection against plasmodium falciparum through a novel approach to account for heterogeneity in malaria exposure. Clin Infect Dis. 2018;66(4):586\u201393. https:\/\/doi.org\/10.1093\/cid\/cix837.","DOI":"10.1093\/cid\/cix837"},{"key":"2061_CR54","doi-asserted-by":"publisher","unstructured":"Greenhouse B, Ho B, Hubbard A, Njama-Meya D, Narum DL, Lanar DE, et al. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis. 2011;204(1):19\u201326. https:\/\/doi.org\/10.1093\/infdis\/jir223.","DOI":"10.1093\/infdis\/jir223"},{"key":"2061_CR55","doi-asserted-by":"publisher","unstructured":"Mayor A, Kumar U, Bardaji A, Gupta P, Jimenez A, Hamad A, et al. Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum. J Infect Dis. 2013;207(11):1664\u201374. https:\/\/doi.org\/10.1093\/infdis\/jit083.","DOI":"10.1093\/infdis\/jit083"},{"key":"2061_CR56","doi-asserted-by":"publisher","unstructured":"Peach E, Morgan C, Scoullar MJL, Fowkes FJI, Kennedy E, Melepia P, et al. Risk factors and knowledge associated with high unintended pregnancy rates and low family planning use among pregnant women in Papua New Guinea. Sci Rep. 2021;11(1):1222. https:\/\/doi.org\/10.1038\/s41598-020-79103-6.","DOI":"10.1038\/s41598-020-79103-6"},{"key":"2061_CR57","doi-asserted-by":"publisher","unstructured":"Scoullar MJL, Boeuf P, Peach E, Fidelis R, Tokmun K, Melepia P, et al. Mycoplasma genitalium and other reproductive tract infections in pregnant women, Papua New Guinea, 2015-2017. Emerg Infect Dis. 2021;27(3):894\u2013904. https:\/\/doi.org\/10.3201\/eid2703.201783.","DOI":"10.3201\/eid2703.201783"},{"key":"2061_CR58","doi-asserted-by":"publisher","unstructured":"Zhou J, Feng G, Beeson J, Hogarth PM, Rogerson SJ, Yan Y, et al. CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so. BMC medicine. 2015;13(1):154. https:\/\/doi.org\/10.1186\/s12916-015-0391-7.","DOI":"10.1186\/s12916-015-0391-7"},{"key":"2061_CR59","doi-asserted-by":"publisher","unstructured":"Feng G, Aitken E, Yosaatmadja F, Kalilani L, Meshnick SR, Jaworowski A, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis. 2009;200(2):299\u2013306. https:\/\/doi.org\/10.1086\/599841.","DOI":"10.1086\/599841"},{"key":"2061_CR60","doi-asserted-by":"publisher","unstructured":"Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun. 2003;71(11):6620\u20133. https:\/\/doi.org\/10.1128\/IAI.71.11.6620-6623.2003.","DOI":"10.1128\/IAI.71.11.6620-6623.2003"},{"key":"2061_CR61","doi-asserted-by":"publisher","unstructured":"Silvestri L, Baker JR, Roden L, Stroud RM. The C1q inhibitor in serum is a chondroitin 4-sulfate proteoglycan. J Biol Chem. 1981;256(14):7383\u20137. https:\/\/doi.org\/10.1016\/S0021-9258(19)68974-X.","DOI":"10.1016\/S0021-9258(19)68974-X"},{"key":"2061_CR62","doi-asserted-by":"publisher","unstructured":"Kurtovic L, Beeson JG. Complement factors in COVID-19 therapeutics and vaccines. Trends Immunol. 2021;42(2):94\u2013103. https:\/\/doi.org\/10.1016\/j.it.2020.12.002.","DOI":"10.1016\/j.it.2020.12.002"},{"key":"2061_CR63","doi-asserted-by":"crossref","unstructured":"Oyong DA, Kenangalem E, Poespoprodjo JR, Beeson JG, Anstey NM, Price RN, et al. Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia. JCI insight. 2018;3:22.","DOI":"10.1172\/jci.insight.124854"},{"key":"2061_CR64","doi-asserted-by":"publisher","unstructured":"Cooke BM, Buckingham DW, Glenister FK, Fernandez KM, Bannister LH, Marti M, et al. A Maurer's cleft-associated protein is essential for expression of the major malaria virulence antigen on the surface of infected red blood cells. J Cell Biol. 2006;172(6):899\u2013908. https:\/\/doi.org\/10.1083\/jcb.200509122.","DOI":"10.1083\/jcb.200509122"},{"issue":"21","key":"2061_CR65","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1007\/s00018-016-2267-1","volume":"73","author":"JA Chan","year":"2016","unstructured":"Chan JA, Howell KB, Langer C, Maier AG, Hasang W, Rogerson SJ, et al. A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies. Cell Mole Life Sci CMLS. 2016;73(21):4141\u201358.","journal-title":"Cell Mole Life Sci CMLS"},{"issue":"1","key":"2061_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1475-2875-10-36","volume":"10","author":"M Avril","year":"2011","unstructured":"Avril M, Cartwright MM, Hathaway MJ, Smith JD. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins. Malar J. 2011;10(1):36. https:\/\/doi.org\/10.1186\/1475-2875-10-36.","journal-title":"Malar J."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02061-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02061-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T20:03:20Z","timestamp":1631217800000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02061-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02061-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.02.21258254","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the PNG Medical Research Advisory Council, the Melbourne Health Human Research Ethics Committee and Alfred Health Human Research Ethics Committee. Eligible women were read a statement describing the study and gave a written informed voluntary consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and approval and consent to participate"}},{"value":"Not applicable. No details, images, or videos relating to an individual person are included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"201"}}